Cue Biopharma (CUE) Current Assets (2017 - 2025)
Historic Current Assets for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $25.8 million.
- Cue Biopharma's Current Assets fell 3069.84% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year decrease of 3069.84%. This contributed to the annual value of $25.1 million for FY2024, which is 5114.47% down from last year.
- Latest data reveals that Cue Biopharma reported Current Assets of $25.8 million as of Q3 2025, which was down 3069.84% from $30.8 million recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Current Assets registered a high of $79.7 million during Q2 2021, and its lowest value of $15.9 million during Q1 2025.
- Its 5-year average for Current Assets is $54.3 million, with a median of $60.9 million in 2023.
- As far as peak fluctuations go, Cue Biopharma's Current Assets soared by 5121.12% in 2021, and later crashed by 6433.54% in 2025.
- Over the past 5 years, Cue Biopharma's Current Assets (Quarter) stood at $68.5 million in 2021, then grew by 12.73% to $77.2 million in 2022, then plummeted by 33.34% to $51.5 million in 2023, then crashed by 51.14% to $25.1 million in 2024, then grew by 2.71% to $25.8 million in 2025.
- Its last three reported values are $25.8 million in Q3 2025, $30.8 million for Q2 2025, and $15.9 million during Q1 2025.